Medications

Q&A: Experts discuss pros, cons of new Alzheimer's drug

Patient care teams are preparing to offer lecanemab, a new Alzheimer's disease treatment expected to soon receive approval from the U.S. Food and Drug Administration (FDA), to patients in the coming months.

Health

Intranasal insulin may have pro-cognitive benefits

Intranasal insulin (INI) seems to have a beneficial effect on global cognition among patients with Alzheimer's disease (AD)/mild cognitive impairment (MCI), according to a review published online June 28 in PLOS ONE.

Arthritis & Rheumatism

How chronic knee osteoarthritis pain affects cognitive function

New research suggests that chronic knee pain caused by osteoarthritis does not cause cognitive impairment in isolation, indicating that other factors like age, pain medication and socio-economic factors are likely to play ...

page 15 from 40